Why is Sun Pharma.Inds. falling/rising?

As of 08-Aug, Sun Pharmaceutical Industries Ltd is experiencing a decline in its stock price, currently at Rs 1,586.70, which reflects a decrease of Rs 11.95 or 0.75%. The stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 2% away from Rs 1,555. The recent performance shows that the stock has underperformed the sector by 0.41% today, and the delivery volume has decreased by 0.4% compared to the 5-day average, suggesting a decline in investor participation. Despite these challenges, the company maintains strong long-term fundamentals, including a low debt-to-equity ratio and healthy growth in net sales and operating profit, which could support its valuation in the long run.
In the broader market context, Sun Pharma's short-term performance has been weaker than the benchmark Sensex, with a 1-week return of -2.60% compared to the Sensex's -0.92%. Over the past month, the stock has declined by 5.15%, while the Sensex has fallen by 4.60%. This underperformance is notable, especially given that the stock has a high institutional holding of 36.75%, which typically indicates a level of confidence among more sophisticated investors. However, the overall market sentiment appears to be affecting the stock negatively, as evidenced by its year-to-date decline of 15.80% against the Sensex's gain of 2.20%.